Truist Financial Increases Integer (NYSE:ITGR) Price Target to $145.00

Integer (NYSE:ITGR) had its price target increased by research analysts at Truist Financial from $137.00 to $145.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Truist Financial’s price objective would indicate a potential upside of 12.05% from the stock’s previous close.

A number of other brokerages have also recently weighed in on ITGR. Oppenheimer assumed coverage on shares of Integer in a report on Tuesday, July 16th. They set an “outperform” rating and a $135.00 target price for the company. Benchmark restated a “buy” rating and issued a $130.00 target price on shares of Integer in a report on Friday, August 2nd. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $135.00.

Integer Stock Performance

Shares of NYSE ITGR traded down $0.59 during midday trading on Tuesday, hitting $129.41. 1,939 shares of the company’s stock were exchanged, compared to its average volume of 315,947. Integer has a twelve month low of $69.40 and a twelve month high of $131.87. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The firm has a market cap of $4.34 billion, a P/E ratio of 44.51, a PEG ratio of 1.87 and a beta of 1.09. The stock’s 50 day moving average price is $123.35 and its 200-day moving average price is $119.22.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.06. The business had revenue of $436.20 million for the quarter, compared to analysts’ expectations of $437.00 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. The company’s revenue was up 9.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.14 earnings per share. Equities research analysts anticipate that Integer will post 5.31 EPS for the current year.

Insider Transactions at Integer

In other Integer news, Director Jean M. Hobby sold 11,960 shares of Integer stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the transaction, the director now owns 2,280 shares of the company’s stock, valued at approximately $272,824.80. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 2.00% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Integer

Several institutional investors and hedge funds have recently modified their holdings of the stock. Public Employees Retirement Association of Colorado grew its stake in Integer by 3,260.1% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider’s stock valued at $28,281,000 after purchasing an additional 276,944 shares in the last quarter. Driehaus Capital Management LLC grew its stake in shares of Integer by 62.5% in the 2nd quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock valued at $40,880,000 after buying an additional 135,750 shares in the last quarter. F M Investments LLC acquired a new position in Integer in the second quarter worth approximately $11,143,000. Point72 Europe London LLP bought a new position in Integer during the second quarter valued at approximately $6,241,000. Finally, Congress Asset Management Co. MA lifted its stake in Integer by 12.5% in the fourth quarter. Congress Asset Management Co. MA now owns 421,524 shares of the medical equipment provider’s stock valued at $41,765,000 after acquiring an additional 46,776 shares during the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.